Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J M, Sánchez Cuenca"'
Autor:
A, García Herola, P, Nos, J, Hinijosa, M, Hoyos, J R, Molés, E, Carmona, N, Puig, J M, Sánchez-Cuenca, J, Ponce, J, Berenguer
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 95(11)
the hypothesis of this study is that genes involved in the regulation of the immune system, expressed by HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA), could be determinants of disease susceptibility and behavior in inflammatory bowe
Publikováno v:
Medicina clinica. 114(6)
Autor:
G, Garrido Palma, J M, Sánchez Cuenca, V, Olaso, R, Pina, J J, Urquijo, B, López Viedma, M, Bustamante, M, Berenguer, J, Berenguer
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 91(3)
The prevalence of antimitochondrial antibodies (AMA) in chronic hepatitis C is 2%; titers of AMA are usually low (1:40). The prevalence decreases to 0.5% when the results are verified by determination of the M2 subtype (anti-M2, ELISA). In patients i
Autor:
A, García-Herola, P, Nos, M, Hoyos, J, Hinojosa, J R, Molés, S, Pascual, M, Bustamante, J M, Sánchez Cuenca, E, Carmona, J, Ponce, J, Berenguer
Publikováno v:
Gastroenterologia y hepatologia. 21(4)
We have studied prospectively 126 consecutive patients recruited with a known diagnosis of ulcerative colitis (UC; n = 78) and Crohn's disease (CD; n = 48) for anti-neutrophil cytoplasmatic antibodies (ANCA) by indirect immunofluorescence (IFI). Fort
Autor:
J M, Sánchez-Cuenca
Publikováno v:
Allergologia et immunopathologia. 22(5)
In 1975, Miller and Nussenzweig described a new function of the Complement (C'): the Capacity of this substance to solubilize "in vitro" antigen/antibody complexes previously formed. Subsequent studies of these authors and other researches (particula
Publikováno v:
Thrombosis and Haemostasis. 54:377-380
SummaryAntibodies against factor-VIII coagulant activity can appear in haemophilic patients and, although infrequently, can affect individuals not suffering from Haemophilia A. The Oxford and Bethesda methods are presently the most commonly used tech
Publikováno v:
Sangre. 30(4-A)
Autor:
F, Llopis, A, González-Molina, J A, Aznar, J I, Jorquera, E, Carmona, M J, Villanueva, A, Trénor, J M, Sánchez-Cuenca
Publikováno v:
Thrombosis and haemostasis. 55(2)
Publikováno v:
Thrombosis and haemostasis. 54(2)
Antibodies against factor-VIII coagulant activity can appear in haemophilic patients and, although infrequently, can affect individuals not suffering from Haemophilia A. The Oxford and Bethesda methods are presently the most commonly used techniques
Autor:
J A, Aznar, J I, Jorquera, A, González Molina, F, Carbonell, A, Trenor, J M, Sánchez Cuenca, R, de Andrés
Publikováno v:
Sangre. 28(5)